Study is funded by ADC Therapeutics and Sobi.

Publication
  • 18th ICML •
  • 20 June, 2025 •
  • •

Initial Results From LOTIS-7: A Phase 1b Study of Loncastuximab Tesirine Plus Glofitamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Juan Pablo Alderuccio, Craig Okada, Gilles Crochet, Emily C. Ayers, Marie Hu, Silvia Ferrari, Paolo Caimi, Mehdi Hamadani, Julien Depaus, Enrico Derenzini, Jose Sandoval-Sus, Ruben Reyes, Andrzej Urban, Erica Rave, Adina Graf, Eva Tiecke, Marie Toukam, Pier Luigi Zinzani

Available materials

Oral Presentation
Symposium
  • 18th ICML •
  • 17 June, 2025 •
  • •

Treatment sequencing in R/R DLBCL: Dissecting the emerging challenge from bench to bedside

Andrew Davies , Romano Danesi, Gloria Lacoboni , Marek Trněný

Available materials

Slides Video
Publication
  • EHA •
  • 14 June, 2025 •
  • •

Updated Safety Run-In Results From LOTIS-5: A Phase 3, Randomized Trial of Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Patients With R/R DLBCL/HGBL

Carmelo Carlo-Stella , Michal Kwiatek , Julien Depaus, Sebastian Grosicki, Sylvia Snauwaert, Edwin Kingsley, Javier López-Jiménez, Blanca Sanchez-Gonzalez, Andrzej Urban, Andrew Niewiarowski, Neus Domper-Rubio, Luqiang Wang, Eva Tiecke, Marie Toukam, Mehdi Hamadani

Available materials

Poster
Symposium
  • EHA •
  • 14 June, 2025 •
  • •

Dissecting Treatment Sequencing in Relapsed/Refractory Diffuse Large B-cell Lymphoma​ From Laboratory to Real Life

Pier Luigi Zinzani, Romano Danesi, Joel Wight, Marek Trněný

Available materials

Slides Video
Sign up for alerts